
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidates address therapeutic areas with a high unmet medical need and strive to provide improved patient be... Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidates address therapeutic areas with a high unmet medical need and strive to provide improved patient benefit by delivering targeted, long-lasting activity with fewer side effects. Its lead product candidate, EP-104IAR, is in development for the treatment of pain due to osteoarthritis of the knee. In addition, it is developing a pipeline of earlier-stage long-acting formulations. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.29 | -6.90476190476 | 4.2 | 4.25 | 3.91 | 11847 | 4.10424836 | CS |
4 | 0.57 | 17.0658682635 | 3.34 | 4.48 | 3.3001 | 23654 | 3.97614068 | CS |
12 | 1.16 | 42.1818181818 | 2.75 | 4.48 | 2.75 | 14828 | 3.64164152 | CS |
26 | 1.06 | 37.1929824561 | 2.85 | 4.48 | 2.2 | 15557 | 3.37693925 | CS |
52 | 0.36 | 10.1408450704 | 3.55 | 4.48 | 2.2 | 15969 | 3.09381601 | CS |
156 | 0.36 | 10.1408450704 | 3.55 | 4.48 | 2.2 | 15969 | 3.09381601 | CS |
260 | 0.36 | 10.1408450704 | 3.55 | 4.48 | 2.2 | 15969 | 3.09381601 | CS |
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관